These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 23443774)
1. [Expression of glypican-3 in lung squamous cell carcinoma and adenocarcinoma and its relation with prognosis]. Li H; Deng Q; Huang L; Tang H; Cheng X Nan Fang Yi Ke Da Xue Xue Bao; 2013 Feb; 33(2):212-5. PubMed ID: 23443774 [TBL] [Abstract][Full Text] [Related]
2. Glypican-3 is overexpressed in lung squamous cell carcinoma, but not in adenocarcinoma. Aviel-Ronen S; Lau SK; Pintilie M; Lau D; Liu N; Tsao MS; Jothy S Mod Pathol; 2008 Jul; 21(7):817-25. PubMed ID: 18469798 [TBL] [Abstract][Full Text] [Related]
3. Differential expression of glypican-3 (GPC3) in lung squamous cell carcinoma and lung adenocarcinoma and its clinical significance. Yu X; Li Y; Chen SW; Shi Y; Xu F Genet Mol Res; 2015 Aug; 14(3):10185-92. PubMed ID: 26345955 [TBL] [Abstract][Full Text] [Related]
4. WIF-1 and Ihh Expression and Clinical Significance in Patients With Lung Squamous Cell Carcinoma and Adenocarcinoma. Zhang Y; Hu C Appl Immunohistochem Mol Morphol; 2018 Aug; 26(7):454-461. PubMed ID: 27801732 [TBL] [Abstract][Full Text] [Related]
5. [Expression of alpha-tubulin and MDR1 and their correlation with the biological features of non-small cell lung carcinoma]. Chen QY; Jiang ZY; Wu LJ; Zhang BY; Lu GH; Zhou JY Zhonghua Zhong Liu Za Zhi; 2010 Apr; 32(4):278-82. PubMed ID: 20510079 [TBL] [Abstract][Full Text] [Related]
6. Utility of 10 immunohistochemical markers including novel markers (desmocollin-3, glypican 3, S100A2, S100A7, and Sox-2) for differential diagnosis of squamous cell carcinoma from adenocarcinoma of the Lung. Tsuta K; Tanabe Y; Yoshida A; Takahashi F; Maeshima AM; Asamura H; Tsuda H J Thorac Oncol; 2011 Jul; 6(7):1190-9. PubMed ID: 21623236 [TBL] [Abstract][Full Text] [Related]
7. [Correlation between expression of long non-coding RNA ZXF1 and prognosis of lung adenocarcinoma and its potential molecular mechanism]. Pan GF; Zhou XF; Zhao JP Zhonghua Zhong Liu Za Zhi; 2017 Feb; 39(2):102-108. PubMed ID: 28219204 [No Abstract] [Full Text] [Related]
8. Expression and roles of lumican in lung adenocarcinoma and squamous cell carcinoma. Matsuda Y; Yamamoto T; Kudo M; Kawahara K; Kawamoto M; Nakajima Y; Koizumi K; Nakazawa N; Ishiwata T; Naito Z Int J Oncol; 2008 Dec; 33(6):1177-85. PubMed ID: 19020750 [TBL] [Abstract][Full Text] [Related]
9. [Clinical significance of syndecan-1 and syndecan-2 expression in gallbladder squamous cell/adenosquamous carcinoma and adenocarcinoma]. Tan XG; Yang ZL; Miao XY; Liu ZR; Li DQ; Zou Q; Li JH; Liang LF Zhonghua Zhong Liu Za Zhi; 2018 Jan; 40(1):28-34. PubMed ID: 29365414 [No Abstract] [Full Text] [Related]
10. Association of PD-L1 expression and PD-L1 gene polymorphism with poor prognosis in lung adenocarcinoma and squamous cell carcinoma. Yeo MK; Choi SY; Seong IO; Suh KS; Kim JM; Kim KH Hum Pathol; 2017 Oct; 68():103-111. PubMed ID: 28851662 [TBL] [Abstract][Full Text] [Related]
11. [Hsp90AB1 Protein is Overexpressed in Non-small Cell Lung Cancer Tissues and Associated with Poor Prognosis in Lung Adenocarcinoma Patients]. Wang M; Feng L; Li P; Han N; Gao Y; Xiao T Zhongguo Fei Ai Za Zhi; 2016 Feb; 19(2):64-9. PubMed ID: 26903158 [TBL] [Abstract][Full Text] [Related]
13. Expression of GPC3 protein and its significance in lung squamous cell carcinoma. Lin Q; Xiong LW; Pan XF; Gen JF; Bao GL; Sha HF; Feng JX; Ji CY; Chen M Med Oncol; 2012 Jun; 29(2):663-9. PubMed ID: 21556932 [TBL] [Abstract][Full Text] [Related]
14. LDHA upregulation independently predicts poor survival in lung adenocarcinoma, but not in lung squamous cell carcinoma. Yu C; Hou L; Cui H; Zhang L; Tan X; Leng X; Li Y Future Oncol; 2018 Oct; 14(24):2483-2492. PubMed ID: 29756998 [TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of TAZ expression in resected non-small cell lung cancer. Xie M; Zhang L; He CS; Hou JH; Lin SX; Hu ZH; Xu F; Zhao HY J Thorac Oncol; 2012 May; 7(5):799-807. PubMed ID: 22481233 [TBL] [Abstract][Full Text] [Related]
16. Significance of tumour cell HLA-G5/-G6 isoform expression in discrimination for adenocarcinoma from squamous cell carcinoma in lung cancer patients. Yan WH; Liu D; Lu HY; Li YY; Zhang X; Lin A J Cell Mol Med; 2015 Apr; 19(4):778-85. PubMed ID: 25689063 [TBL] [Abstract][Full Text] [Related]
17. [Expression and significance of membrane skeleton protein 4.1 family in non-small cell lung cancer]. Zheng XY; Qi YM; Gao YF; Wang XY; Qi MX; Shi XF; An XL Ai Zheng; 2009 Jul; 28(7):679-84. PubMed ID: 19624891 [TBL] [Abstract][Full Text] [Related]
18. Co-expression of podoplanin and fibroblast growth factor 1 predicts poor prognosis in patients with lung squamous cell carcinoma. Li J; Chen H; Li X; Wang L; Gao A; Zhang P; Lin W; Gao W; Yang D; Guo X; Liu J; Dang Q; Sun Y Mol Med Rep; 2017 Aug; 16(2):1643-1652. PubMed ID: 28656229 [TBL] [Abstract][Full Text] [Related]
19. Expression of integrin-linked kinase in lung squamous cell carcinoma and adenocarcinoma: correlation with E-cadherin expression, tumor microvessel density and clinical outcome. Yu J; Shi R; Zhang D; Wang E; Qiu X Virchows Arch; 2011 Jan; 458(1):99-107. PubMed ID: 21136077 [TBL] [Abstract][Full Text] [Related]
20. [Expression of PKB protein in human squamous-cell carcinoma and adenocarcinoma of lung]. Liao YD; Long QH; Zhou S; Zhao JP; Huang Q; Fu XN Zhonghua Zhong Liu Za Zhi; 2005 Mar; 27(3):156-9. PubMed ID: 15946565 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]